Kinaset Therapeutics

Kinaset Therapeutics

Latest funding
$40,000,000
Venture capital (Series A) - 2020
Atlas Venture Gimv 5AM Ventures
Team Size
1–10
Employees
$40,000,000 Venture capital (Series A)
WSJ Venture Capital

Kinaset Therapeutics Launches With $40 Million Series A to Advance Asthma Drug